Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Paraconic acid, also known as 4-methyl-3-cyclohexene-1-carboxylic acid, is an organic compound with the chemical formula C7H10O2. It is a colorless liquid with a pungent odor and is derived from the oxidation of paraconic alcohol. Paraconic acid is used as an intermediate in the synthesis of various pharmaceuticals, agrochemicals, and other specialty chemicals. It is also employed in the production of fragrances and flavorings. Due to its versatile applications, paraconic acid plays a significant role in the chemical industry.

5352-72-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 5352-72-7 Structure
  • Basic information

    1. Product Name: paraconic acid
    2. Synonyms: itamalic acid γ-lactone;paraconic acid;tetrahydro-5-oxo-3-furancarboxylic acid
    3. CAS NO:5352-72-7
    4. Molecular Formula: C5H6O4
    5. Molecular Weight: 354.84836
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 5352-72-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 578.8°Cat760mmHg
    3. Flash Point: 303.8°C
    4. Appearance: /
    5. Density: 1.315g/cm3
    6. Vapor Pressure: 3.08E-14mmHg at 25°C
    7. Refractive Index: 1.593
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: paraconic acid(CAS DataBase Reference)
    11. NIST Chemistry Reference: paraconic acid(5352-72-7)
    12. EPA Substance Registry System: paraconic acid(5352-72-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 5352-72-7(Hazardous Substances Data)

5352-72-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5352-72-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,3,5 and 2 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 5352-72:
(6*5)+(5*3)+(4*5)+(3*2)+(2*7)+(1*2)=87
87 % 10 = 7
So 5352-72-7 is a valid CAS Registry Number.
InChI:InChI=1/C17H19ClO4S/c18-16-8-6-15(7-9-16)12-23(20,21)13-17(19)11-22-10-14-4-2-1-3-5-14/h1-9,17,19H,10-13H2

5352-72-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[(4-chlorophenyl)methylsulfonyl]-3-phenylmethoxypropan-2-ol

1.2 Other means of identification

Product number -
Other names HMS2503I16

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5352-72-7 SDS

5352-72-7Relevant articles and documents

Asymmetric Conjugate Addition of Chiral Secondary Borylalkyl Copper Species

Jang, Won Jun,Woo, Jeongkyu,Yun, Jaesook

supporting information, p. 4614 - 4618 (2021/01/18)

We report the diastereo- and enantioselective conjugate addition of chiral secondary borylalkyl copper species derived from borylalkenes in situ to α,β-unsaturated diesters. In the presence of a chiral bisphosphine-ligated CuH catalyst, the conjugate addition provides a direct access to enantioenriched alkylboron compounds containing two contiguous carbon stereogenic centers in good yield with high diastereo- and enantioselectivity (up to >98:2 dr, >99:1 er) by assembling readily available starting alkenyl reagents in a single operation without using preformed organometallic reagents or chiral auxiliaries. The resulting products were used in various organic transformations. The utility of the synthetic approach was highlighted by the synthesis of (?)-phaseolinic acid.

Topical ‘dual-soft’ glucocorticoid receptor agonist for dermatology

Carnerup, Martin A.,Dack, Kevin N.,Eirefelt, Stefan,Henriksson, Krister,Johnson, Patrick S.,Ollerstam, Anna K.,Stahlhut, Martin

supporting information, (2020/07/21)

Steroidal glucocorticoids (GR agonists) have been widely used for the topical treatment of skin disorders, including atopic dermatitis. They are a very effective therapy, but they are associated with both unwanted local effects in the skin (skin thinning/atrophy) and systemic side effects. These effects can limit the long-term utility of potent steroids. Here we report on a topically delivered non-steroidal GR agonist, that has the potential to deliver high efficacy in the skin, but due to rapid metabolism in the blood & liver (“dual-soft”) it should have greater systemic safety than existing treatments. In addition, compared to less selective steroidal GR agonists, the new non-steroidal Selective Glucocorticoid Agonists (SEGRAs) have the potential to avoid the skin atrophy observed with existing topical steroids. Due to its potential for reduced skin atrophy and low systemic exposure, LEO 134310 (17) may be suitable for long term topical treatment of skin diseases such as atopic dermatitis and psoriasis.

NON-STEROIDAL GLUCOCORTICOID RECEPTOR MODULATORS FOR LOCAL DRUG DELIVERY

-

Page/Page column 57; 58, (2017/04/11)

The present invention relates to a compound according to formula (I) wherein R1 is selected from the group consisting of 5- and 6- membered heteroaryl, (C1- C6)alkyl, (C3-C6)cycloalkyl, (4-6)-membered heterocycloalkyl and phenyl; R2 is selected from (C1-C3)alkyl and halo(C1-C3)alkyl; R3 is selected from phenyl, 5-membered heteroaryl and 6-membered heteroaryl; R4 is selected from hydrogen, halogen, (C1- C4)alkyl and halo(C1-C4)alkyl; X1 is selected from CH, C(Rb) and N, X2 is selected from CH and N; Y is selected from -NH- and -O-; m is 0 or 1; n is 0 or 1; L represents a bond, -O-, -NH- or -N(RC)-; or pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention relates further to intermediates for the preparation of said compounds, to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases with said compounds, and to the use of said compounds in the manufacture of medicaments.

Stereoselective formation of a functionalized dipeptide isostere by zinc carbenoid-mediated chain extension

Lin, Weimin,Theberge, Cory R.,Henderson, Timothy J.,Zercher, Charles K.,Jasinski, Jerry,Butcher, Ray J.

supporting information; experimental part, p. 645 - 651 (2009/07/04)

The application of a zinc carbenoid-mediated chain-extension reaction to a functionalized peptide isostere is reported. The cleavage site of human CVM protease was utilized as a target for testing the synthetic methodology. The utility of this chain-exten

Formation of γ-lactones through CAN-mediated oxidative cleavage of hemiketals

Jacobine, Alexander M.,Lin, Weimin,Walls, Bethany,Zercher, Charles K.

supporting information; experimental part, p. 7409 - 7412 (2009/05/07)

(Chemical Equation Presented) The generation of substituted γ-lactones can be accomplished through application of a tandem chain extension-aldol reaction, followed by CAN-mediated oxidative cleavage of the aldol product. The oxidative cleavage requires the intermediacy of a hemiketal and the presence of an α-heteroatom. Formation of the γ-lactone through the oxidative cleavage is used to assign stereochemistry of the aldol reaction and as the final step in a short synthesis of members of the phaseolinic acid family of natural products.

Chemoenzymatic synthesis of enantioenriched 5-oxo-tetrahydro-3- furancarboxylic acid derivatives

Comini, Andrea,Forzato, Cristina,Nitti, Patrizia,Pitacco, Giuliana,Valentin, Ennio

, p. 617 - 625 (2007/10/03)

(R)-(+)-Paraconic acid 4, (S)-(-)-terebic acid 6 and their corresponding methyl and ethyl esters having ee's ranging from 60% to 92% were obtained by enzymatic resolution of their racemates. The enzymatic resolution of racemic ethyl γ-methylparaconates 14a and 14b allowed the isolation of the unreacted ester (2R,3R)-(+)-14a and that of the lactonic acid (2S,3R)-(-)-5b with 80% and 93% ee, respectively, the former by the use of Horse liver acetone powder (HLAP), the latter using α-chymotrypsin (α-CT). The enantiomeric ethyl (2S,3S)-(-)-14a and (2S,3R)-(-)-14b, both with >99% ee, were obtained by baker's yeast reduction of diethyl acetylsuccinate.

Preparative Bioorganic Chemistry, XI. - Preparation of the Enantiomers of Paraconic Acid Employing Lipase-Mediated Asymmetric Hydrolysis of Prochiral Diacetates as the Key Step

Mori, Kenji,Chiba, Naoki

, p. 957 - 962 (2007/10/02)

(S)-(-)-Paraconic acid (1) was prepared from 2-(acetoxymethyl)-3-phenylpropyl acetate (4) by its asymmetric hydrolysis with pig pancreatic lipase as the key step.Similarly, (R)-(+)-1 was prepared from 2-(acetoxymethyl)-4-pentenyl acetate (2) by its asymme

SYNTHESIS OF OPTICALLY ACTIVE FORMS OF A-FACTOR, THE INDUCER OF STREPTOMYCIN BIOSYNTHESIS IN INACTIVE MUTANTS OF STREPTOMYCES GRISEUS

Mori, Kenji,Yamane, Kazusuke

, p. 2919 - 2921 (2007/10/02)

The absolute configuration at C-3 of A-factor, 2-(6-methylheptanoyl)-3-hydroxymethyl-4-butanolide 1a, was determined to be S by synthesizing both enantiomers of it from paraconic acid. (3S)-A-factor was 2.5 times more active than the (3R)-isomer as the inducer of streptomycin biosynthesis in inactive mutants of Streptomyces griseus.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5352-72-7